The Relief Therapeutics Holding AG (OTC: RLFTF) stock has slumped by 3% this morning after the company sent out a notice to shareholders with regards to the Annual General Meeting that is going to be held on June 18, 2021.
The company went on to specify that due to the roles in place owing to the coronavirus pandemic, the shareholders would not need to be present physically at the meeting. In addition to that, Relief also listed all the agendas that are going to be the subjects of the meeting.
Investors who are interested in learning about the agendas of the meeting in full can visit the company’s website and look into the investor relations section. Relief Therapeutics has come into sharp focus in recent times due to the work that it has put in to develop the compound RLF 100, which is meant for the treatment of patients suffering from severe symptoms of COVID 19 infection.
Biotech, Tech, and Crypto reporter
Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.